Pharma & Healthcare
Global Recombinant FSH Injections Market Research Report 2025
- Sep 24, 25
- ID: 523099
- Pages: 85
- Figures: 85
- Views: 5
Report Scope
This report aims to provide a comprehensive presentation of the global market for Recombinant FSH Injections, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant FSH Injections.
The Recombinant FSH Injections market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant FSH Injections market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant FSH Injections manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Gonal-F (Merck)
Follistim (Organon)
Bravelle (Ferring)
Menopur (Ferring)
Fostimon (IBSA)
Puregon (Organon)
BEMFOLA (Gedeon Richter)
Follitrope (LG Chem)
GenSci
Segment by Type
Powder
Liquid
Segment by Application
IVF and Embryo Transfer
Infertility Treatment
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Recombinant FSH Injections manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Recombinant FSH Injections in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
This report aims to provide a comprehensive presentation of the global market for Recombinant FSH Injections, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant FSH Injections.
The Recombinant FSH Injections market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant FSH Injections market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant FSH Injections manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Gonal-F (Merck)
Follistim (Organon)
Bravelle (Ferring)
Menopur (Ferring)
Fostimon (IBSA)
Puregon (Organon)
BEMFOLA (Gedeon Richter)
Follitrope (LG Chem)
GenSci
Segment by Type
Powder
Liquid
Segment by Application
IVF and Embryo Transfer
Infertility Treatment
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Recombinant FSH Injections manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Recombinant FSH Injections in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Recombinant FSH Injections Market Overview
1.1 Product Definition
1.2 Recombinant FSH Injections by Type
1.2.1 Global Recombinant FSH Injections Market Value Comparison by Type (2024 VS 2031)
1.2.2 Powder
1.2.3 Liquid
1.3 Recombinant FSH Injections by Application
1.3.1 Global Recombinant FSH Injections Market Value by Application (2024 VS 2031)
1.3.2 IVF and Embryo Transfer
1.3.3 Infertility Treatment
1.4 Global Recombinant FSH Injections Market Size Estimates and Forecasts
1.4.1 Global Recombinant FSH Injections Revenue 2020-2031
1.4.2 Global Recombinant FSH Injections Sales 2020-2031
1.4.3 Global Recombinant FSH Injections Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Recombinant FSH Injections Market Competition by Manufacturers
2.1 Global Recombinant FSH Injections Sales Market Share by Manufacturers (2020-2025)
2.2 Global Recombinant FSH Injections Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Recombinant FSH Injections Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Recombinant FSH Injections, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Recombinant FSH Injections, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Recombinant FSH Injections, Product Type & Application
2.7 Global Key Manufacturers of Recombinant FSH Injections, Date of Enter into This Industry
2.8 Global Recombinant FSH Injections Market Competitive Situation and Trends
2.8.1 Global Recombinant FSH Injections Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Recombinant FSH Injections Players Market Share by Revenue
2.8.3 Global Recombinant FSH Injections Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Recombinant FSH Injections Market Scenario by Region
3.1 Global Recombinant FSH Injections Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Recombinant FSH Injections Sales by Region: 2020-2031
3.2.1 Global Recombinant FSH Injections Sales by Region: 2020-2025
3.2.2 Global Recombinant FSH Injections Sales by Region: 2026-2031
3.3 Global Recombinant FSH Injections Revenue by Region: 2020-2031
3.3.1 Global Recombinant FSH Injections Revenue by Region: 2020-2025
3.3.2 Global Recombinant FSH Injections Revenue by Region: 2026-2031
3.4 North America Recombinant FSH Injections Market Facts & Figures by Country
3.4.1 North America Recombinant FSH Injections Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Recombinant FSH Injections Sales by Country (2020-2031)
3.4.3 North America Recombinant FSH Injections Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Recombinant FSH Injections Market Facts & Figures by Country
3.5.1 Europe Recombinant FSH Injections Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Recombinant FSH Injections Sales by Country (2020-2031)
3.5.3 Europe Recombinant FSH Injections Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant FSH Injections Market Facts & Figures by Region
3.6.1 Asia Pacific Recombinant FSH Injections Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Recombinant FSH Injections Sales by Region (2020-2031)
3.6.3 Asia Pacific Recombinant FSH Injections Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Recombinant FSH Injections Market Facts & Figures by Country
3.7.1 Latin America Recombinant FSH Injections Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Recombinant FSH Injections Sales by Country (2020-2031)
3.7.3 Latin America Recombinant FSH Injections Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Recombinant FSH Injections Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant FSH Injections Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Recombinant FSH Injections Sales by Country (2020-2031)
3.8.3 Middle East and Africa Recombinant FSH Injections Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Recombinant FSH Injections Sales by Type (2020-2031)
4.1.1 Global Recombinant FSH Injections Sales by Type (2020-2025)
4.1.2 Global Recombinant FSH Injections Sales by Type (2026-2031)
4.1.3 Global Recombinant FSH Injections Sales Market Share by Type (2020-2031)
4.2 Global Recombinant FSH Injections Revenue by Type (2020-2031)
4.2.1 Global Recombinant FSH Injections Revenue by Type (2020-2025)
4.2.2 Global Recombinant FSH Injections Revenue by Type (2026-2031)
4.2.3 Global Recombinant FSH Injections Revenue Market Share by Type (2020-2031)
4.3 Global Recombinant FSH Injections Price by Type (2020-2031)
5 Segment by Application
5.1 Global Recombinant FSH Injections Sales by Application (2020-2031)
5.1.1 Global Recombinant FSH Injections Sales by Application (2020-2025)
5.1.2 Global Recombinant FSH Injections Sales by Application (2026-2031)
5.1.3 Global Recombinant FSH Injections Sales Market Share by Application (2020-2031)
5.2 Global Recombinant FSH Injections Revenue by Application (2020-2031)
5.2.1 Global Recombinant FSH Injections Revenue by Application (2020-2025)
5.2.2 Global Recombinant FSH Injections Revenue by Application (2026-2031)
5.2.3 Global Recombinant FSH Injections Revenue Market Share by Application (2020-2031)
5.3 Global Recombinant FSH Injections Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Gonal-F (Merck)
6.1.1 Gonal-F (Merck) Company Information
6.1.2 Gonal-F (Merck) Description and Business Overview
6.1.3 Gonal-F (Merck) Recombinant FSH Injections Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Gonal-F (Merck) Recombinant FSH Injections Product Portfolio
6.1.5 Gonal-F (Merck) Recent Developments/Updates
6.2 Follistim (Organon)
6.2.1 Follistim (Organon) Company Information
6.2.2 Follistim (Organon) Description and Business Overview
6.2.3 Follistim (Organon) Recombinant FSH Injections Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Follistim (Organon) Recombinant FSH Injections Product Portfolio
6.2.5 Follistim (Organon) Recent Developments/Updates
6.3 Bravelle (Ferring)
6.3.1 Bravelle (Ferring) Company Information
6.3.2 Bravelle (Ferring) Description and Business Overview
6.3.3 Bravelle (Ferring) Recombinant FSH Injections Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bravelle (Ferring) Recombinant FSH Injections Product Portfolio
6.3.5 Bravelle (Ferring) Recent Developments/Updates
6.4 Menopur (Ferring)
6.4.1 Menopur (Ferring) Company Information
6.4.2 Menopur (Ferring) Description and Business Overview
6.4.3 Menopur (Ferring) Recombinant FSH Injections Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Menopur (Ferring) Recombinant FSH Injections Product Portfolio
6.4.5 Menopur (Ferring) Recent Developments/Updates
6.5 Fostimon (IBSA)
6.5.1 Fostimon (IBSA) Company Information
6.5.2 Fostimon (IBSA) Description and Business Overview
6.5.3 Fostimon (IBSA) Recombinant FSH Injections Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Fostimon (IBSA) Recombinant FSH Injections Product Portfolio
6.5.5 Fostimon (IBSA) Recent Developments/Updates
6.6 Puregon (Organon)
6.6.1 Puregon (Organon) Company Information
6.6.2 Puregon (Organon) Description and Business Overview
6.6.3 Puregon (Organon) Recombinant FSH Injections Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Puregon (Organon) Recombinant FSH Injections Product Portfolio
6.6.5 Puregon (Organon) Recent Developments/Updates
6.7 BEMFOLA (Gedeon Richter)
6.7.1 BEMFOLA (Gedeon Richter) Company Information
6.7.2 BEMFOLA (Gedeon Richter) Description and Business Overview
6.7.3 BEMFOLA (Gedeon Richter) Recombinant FSH Injections Sales, Revenue and Gross Margin (2020-2025)
6.7.4 BEMFOLA (Gedeon Richter) Recombinant FSH Injections Product Portfolio
6.7.5 BEMFOLA (Gedeon Richter) Recent Developments/Updates
6.8 Follitrope (LG Chem)
6.8.1 Follitrope (LG Chem) Company Information
6.8.2 Follitrope (LG Chem) Description and Business Overview
6.8.3 Follitrope (LG Chem) Recombinant FSH Injections Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Follitrope (LG Chem) Recombinant FSH Injections Product Portfolio
6.8.5 Follitrope (LG Chem) Recent Developments/Updates
6.9 GenSci
6.9.1 GenSci Company Information
6.9.2 GenSci Description and Business Overview
6.9.3 GenSci Recombinant FSH Injections Sales, Revenue and Gross Margin (2020-2025)
6.9.4 GenSci Recombinant FSH Injections Product Portfolio
6.9.5 GenSci Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant FSH Injections Industry Chain Analysis
7.2 Recombinant FSH Injections Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant FSH Injections Production Mode & Process Analysis
7.4 Recombinant FSH Injections Sales and Marketing
7.4.1 Recombinant FSH Injections Sales Channels
7.4.2 Recombinant FSH Injections Distributors
7.5 Recombinant FSH Injections Customer Analysis
8 Recombinant FSH Injections Market Dynamics
8.1 Recombinant FSH Injections Industry Trends
8.2 Recombinant FSH Injections Market Drivers
8.3 Recombinant FSH Injections Market Challenges
8.4 Recombinant FSH Injections Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Recombinant FSH Injections by Type
1.2.1 Global Recombinant FSH Injections Market Value Comparison by Type (2024 VS 2031)
1.2.2 Powder
1.2.3 Liquid
1.3 Recombinant FSH Injections by Application
1.3.1 Global Recombinant FSH Injections Market Value by Application (2024 VS 2031)
1.3.2 IVF and Embryo Transfer
1.3.3 Infertility Treatment
1.4 Global Recombinant FSH Injections Market Size Estimates and Forecasts
1.4.1 Global Recombinant FSH Injections Revenue 2020-2031
1.4.2 Global Recombinant FSH Injections Sales 2020-2031
1.4.3 Global Recombinant FSH Injections Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Recombinant FSH Injections Market Competition by Manufacturers
2.1 Global Recombinant FSH Injections Sales Market Share by Manufacturers (2020-2025)
2.2 Global Recombinant FSH Injections Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Recombinant FSH Injections Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Recombinant FSH Injections, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Recombinant FSH Injections, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Recombinant FSH Injections, Product Type & Application
2.7 Global Key Manufacturers of Recombinant FSH Injections, Date of Enter into This Industry
2.8 Global Recombinant FSH Injections Market Competitive Situation and Trends
2.8.1 Global Recombinant FSH Injections Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Recombinant FSH Injections Players Market Share by Revenue
2.8.3 Global Recombinant FSH Injections Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Recombinant FSH Injections Market Scenario by Region
3.1 Global Recombinant FSH Injections Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Recombinant FSH Injections Sales by Region: 2020-2031
3.2.1 Global Recombinant FSH Injections Sales by Region: 2020-2025
3.2.2 Global Recombinant FSH Injections Sales by Region: 2026-2031
3.3 Global Recombinant FSH Injections Revenue by Region: 2020-2031
3.3.1 Global Recombinant FSH Injections Revenue by Region: 2020-2025
3.3.2 Global Recombinant FSH Injections Revenue by Region: 2026-2031
3.4 North America Recombinant FSH Injections Market Facts & Figures by Country
3.4.1 North America Recombinant FSH Injections Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Recombinant FSH Injections Sales by Country (2020-2031)
3.4.3 North America Recombinant FSH Injections Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Recombinant FSH Injections Market Facts & Figures by Country
3.5.1 Europe Recombinant FSH Injections Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Recombinant FSH Injections Sales by Country (2020-2031)
3.5.3 Europe Recombinant FSH Injections Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant FSH Injections Market Facts & Figures by Region
3.6.1 Asia Pacific Recombinant FSH Injections Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Recombinant FSH Injections Sales by Region (2020-2031)
3.6.3 Asia Pacific Recombinant FSH Injections Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Recombinant FSH Injections Market Facts & Figures by Country
3.7.1 Latin America Recombinant FSH Injections Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Recombinant FSH Injections Sales by Country (2020-2031)
3.7.3 Latin America Recombinant FSH Injections Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Recombinant FSH Injections Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant FSH Injections Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Recombinant FSH Injections Sales by Country (2020-2031)
3.8.3 Middle East and Africa Recombinant FSH Injections Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Recombinant FSH Injections Sales by Type (2020-2031)
4.1.1 Global Recombinant FSH Injections Sales by Type (2020-2025)
4.1.2 Global Recombinant FSH Injections Sales by Type (2026-2031)
4.1.3 Global Recombinant FSH Injections Sales Market Share by Type (2020-2031)
4.2 Global Recombinant FSH Injections Revenue by Type (2020-2031)
4.2.1 Global Recombinant FSH Injections Revenue by Type (2020-2025)
4.2.2 Global Recombinant FSH Injections Revenue by Type (2026-2031)
4.2.3 Global Recombinant FSH Injections Revenue Market Share by Type (2020-2031)
4.3 Global Recombinant FSH Injections Price by Type (2020-2031)
5 Segment by Application
5.1 Global Recombinant FSH Injections Sales by Application (2020-2031)
5.1.1 Global Recombinant FSH Injections Sales by Application (2020-2025)
5.1.2 Global Recombinant FSH Injections Sales by Application (2026-2031)
5.1.3 Global Recombinant FSH Injections Sales Market Share by Application (2020-2031)
5.2 Global Recombinant FSH Injections Revenue by Application (2020-2031)
5.2.1 Global Recombinant FSH Injections Revenue by Application (2020-2025)
5.2.2 Global Recombinant FSH Injections Revenue by Application (2026-2031)
5.2.3 Global Recombinant FSH Injections Revenue Market Share by Application (2020-2031)
5.3 Global Recombinant FSH Injections Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Gonal-F (Merck)
6.1.1 Gonal-F (Merck) Company Information
6.1.2 Gonal-F (Merck) Description and Business Overview
6.1.3 Gonal-F (Merck) Recombinant FSH Injections Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Gonal-F (Merck) Recombinant FSH Injections Product Portfolio
6.1.5 Gonal-F (Merck) Recent Developments/Updates
6.2 Follistim (Organon)
6.2.1 Follistim (Organon) Company Information
6.2.2 Follistim (Organon) Description and Business Overview
6.2.3 Follistim (Organon) Recombinant FSH Injections Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Follistim (Organon) Recombinant FSH Injections Product Portfolio
6.2.5 Follistim (Organon) Recent Developments/Updates
6.3 Bravelle (Ferring)
6.3.1 Bravelle (Ferring) Company Information
6.3.2 Bravelle (Ferring) Description and Business Overview
6.3.3 Bravelle (Ferring) Recombinant FSH Injections Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bravelle (Ferring) Recombinant FSH Injections Product Portfolio
6.3.5 Bravelle (Ferring) Recent Developments/Updates
6.4 Menopur (Ferring)
6.4.1 Menopur (Ferring) Company Information
6.4.2 Menopur (Ferring) Description and Business Overview
6.4.3 Menopur (Ferring) Recombinant FSH Injections Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Menopur (Ferring) Recombinant FSH Injections Product Portfolio
6.4.5 Menopur (Ferring) Recent Developments/Updates
6.5 Fostimon (IBSA)
6.5.1 Fostimon (IBSA) Company Information
6.5.2 Fostimon (IBSA) Description and Business Overview
6.5.3 Fostimon (IBSA) Recombinant FSH Injections Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Fostimon (IBSA) Recombinant FSH Injections Product Portfolio
6.5.5 Fostimon (IBSA) Recent Developments/Updates
6.6 Puregon (Organon)
6.6.1 Puregon (Organon) Company Information
6.6.2 Puregon (Organon) Description and Business Overview
6.6.3 Puregon (Organon) Recombinant FSH Injections Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Puregon (Organon) Recombinant FSH Injections Product Portfolio
6.6.5 Puregon (Organon) Recent Developments/Updates
6.7 BEMFOLA (Gedeon Richter)
6.7.1 BEMFOLA (Gedeon Richter) Company Information
6.7.2 BEMFOLA (Gedeon Richter) Description and Business Overview
6.7.3 BEMFOLA (Gedeon Richter) Recombinant FSH Injections Sales, Revenue and Gross Margin (2020-2025)
6.7.4 BEMFOLA (Gedeon Richter) Recombinant FSH Injections Product Portfolio
6.7.5 BEMFOLA (Gedeon Richter) Recent Developments/Updates
6.8 Follitrope (LG Chem)
6.8.1 Follitrope (LG Chem) Company Information
6.8.2 Follitrope (LG Chem) Description and Business Overview
6.8.3 Follitrope (LG Chem) Recombinant FSH Injections Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Follitrope (LG Chem) Recombinant FSH Injections Product Portfolio
6.8.5 Follitrope (LG Chem) Recent Developments/Updates
6.9 GenSci
6.9.1 GenSci Company Information
6.9.2 GenSci Description and Business Overview
6.9.3 GenSci Recombinant FSH Injections Sales, Revenue and Gross Margin (2020-2025)
6.9.4 GenSci Recombinant FSH Injections Product Portfolio
6.9.5 GenSci Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant FSH Injections Industry Chain Analysis
7.2 Recombinant FSH Injections Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant FSH Injections Production Mode & Process Analysis
7.4 Recombinant FSH Injections Sales and Marketing
7.4.1 Recombinant FSH Injections Sales Channels
7.4.2 Recombinant FSH Injections Distributors
7.5 Recombinant FSH Injections Customer Analysis
8 Recombinant FSH Injections Market Dynamics
8.1 Recombinant FSH Injections Industry Trends
8.2 Recombinant FSH Injections Market Drivers
8.3 Recombinant FSH Injections Market Challenges
8.4 Recombinant FSH Injections Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Recombinant FSH Injections Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Recombinant FSH Injections Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Recombinant FSH Injections Market Competitive Situation by Manufacturers in 2024
Table 4. Global Recombinant FSH Injections Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Recombinant FSH Injections Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Recombinant FSH Injections Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Recombinant FSH Injections Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Recombinant FSH Injections Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Recombinant FSH Injections, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Recombinant FSH Injections, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Recombinant FSH Injections, Product Type & Application
Table 12. Global Key Manufacturers of Recombinant FSH Injections, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Recombinant FSH Injections by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant FSH Injections as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Recombinant FSH Injections Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Recombinant FSH Injections Sales by Region (2020-2025) & (K Units)
Table 18. Global Recombinant FSH Injections Sales Market Share by Region (2020-2025)
Table 19. Global Recombinant FSH Injections Sales by Region (2026-2031) & (K Units)
Table 20. Global Recombinant FSH Injections Sales Market Share by Region (2026-2031)
Table 21. Global Recombinant FSH Injections Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Recombinant FSH Injections Revenue Market Share by Region (2020-2025)
Table 23. Global Recombinant FSH Injections Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Recombinant FSH Injections Revenue Market Share by Region (2026-2031)
Table 25. North America Recombinant FSH Injections Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Recombinant FSH Injections Sales by Country (2020-2025) & (K Units)
Table 27. North America Recombinant FSH Injections Sales by Country (2026-2031) & (K Units)
Table 28. North America Recombinant FSH Injections Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Recombinant FSH Injections Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Recombinant FSH Injections Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Recombinant FSH Injections Sales by Country (2020-2025) & (K Units)
Table 32. Europe Recombinant FSH Injections Sales by Country (2026-2031) & (K Units)
Table 33. Europe Recombinant FSH Injections Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Recombinant FSH Injections Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Recombinant FSH Injections Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Recombinant FSH Injections Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Recombinant FSH Injections Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Recombinant FSH Injections Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Recombinant FSH Injections Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Recombinant FSH Injections Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Recombinant FSH Injections Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Recombinant FSH Injections Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Recombinant FSH Injections Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Recombinant FSH Injections Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Recombinant FSH Injections Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Recombinant FSH Injections Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Recombinant FSH Injections Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Recombinant FSH Injections Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Recombinant FSH Injections Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Recombinant FSH Injections Sales (K Units) by Type (2020-2025)
Table 51. Global Recombinant FSH Injections Sales (K Units) by Type (2026-2031)
Table 52. Global Recombinant FSH Injections Sales Market Share by Type (2020-2025)
Table 53. Global Recombinant FSH Injections Sales Market Share by Type (2026-2031)
Table 54. Global Recombinant FSH Injections Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Recombinant FSH Injections Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Recombinant FSH Injections Revenue Market Share by Type (2020-2025)
Table 57. Global Recombinant FSH Injections Revenue Market Share by Type (2026-2031)
Table 58. Global Recombinant FSH Injections Price (US$/Unit) by Type (2020-2025)
Table 59. Global Recombinant FSH Injections Price (US$/Unit) by Type (2026-2031)
Table 60. Global Recombinant FSH Injections Sales (K Units) by Application (2020-2025)
Table 61. Global Recombinant FSH Injections Sales (K Units) by Application (2026-2031)
Table 62. Global Recombinant FSH Injections Sales Market Share by Application (2020-2025)
Table 63. Global Recombinant FSH Injections Sales Market Share by Application (2026-2031)
Table 64. Global Recombinant FSH Injections Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Recombinant FSH Injections Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Recombinant FSH Injections Revenue Market Share by Application (2020-2025)
Table 67. Global Recombinant FSH Injections Revenue Market Share by Application (2026-2031)
Table 68. Global Recombinant FSH Injections Price (US$/Unit) by Application (2020-2025)
Table 69. Global Recombinant FSH Injections Price (US$/Unit) by Application (2026-2031)
Table 70. Gonal-F (Merck) Company Information
Table 71. Gonal-F (Merck) Description and Business Overview
Table 72. Gonal-F (Merck) Recombinant FSH Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Gonal-F (Merck) Recombinant FSH Injections Product
Table 74. Gonal-F (Merck) Recent Developments/Updates
Table 75. Follistim (Organon) Company Information
Table 76. Follistim (Organon) Description and Business Overview
Table 77. Follistim (Organon) Recombinant FSH Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Follistim (Organon) Recombinant FSH Injections Product
Table 79. Follistim (Organon) Recent Developments/Updates
Table 80. Bravelle (Ferring) Company Information
Table 81. Bravelle (Ferring) Description and Business Overview
Table 82. Bravelle (Ferring) Recombinant FSH Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Bravelle (Ferring) Recombinant FSH Injections Product
Table 84. Bravelle (Ferring) Recent Developments/Updates
Table 85. Menopur (Ferring) Company Information
Table 86. Menopur (Ferring) Description and Business Overview
Table 87. Menopur (Ferring) Recombinant FSH Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Menopur (Ferring) Recombinant FSH Injections Product
Table 89. Menopur (Ferring) Recent Developments/Updates
Table 90. Fostimon (IBSA) Company Information
Table 91. Fostimon (IBSA) Description and Business Overview
Table 92. Fostimon (IBSA) Recombinant FSH Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Fostimon (IBSA) Recombinant FSH Injections Product
Table 94. Fostimon (IBSA) Recent Developments/Updates
Table 95. Puregon (Organon) Company Information
Table 96. Puregon (Organon) Description and Business Overview
Table 97. Puregon (Organon) Recombinant FSH Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Puregon (Organon) Recombinant FSH Injections Product
Table 99. Puregon (Organon) Recent Developments/Updates
Table 100. BEMFOLA (Gedeon Richter) Company Information
Table 101. BEMFOLA (Gedeon Richter) Description and Business Overview
Table 102. BEMFOLA (Gedeon Richter) Recombinant FSH Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. BEMFOLA (Gedeon Richter) Recombinant FSH Injections Product
Table 104. BEMFOLA (Gedeon Richter) Recent Developments/Updates
Table 105. Follitrope (LG Chem) Company Information
Table 106. Follitrope (LG Chem) Description and Business Overview
Table 107. Follitrope (LG Chem) Recombinant FSH Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Follitrope (LG Chem) Recombinant FSH Injections Product
Table 109. Follitrope (LG Chem) Recent Developments/Updates
Table 110. GenSci Company Information
Table 111. GenSci Description and Business Overview
Table 112. GenSci Recombinant FSH Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. GenSci Recombinant FSH Injections Product
Table 114. GenSci Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Recombinant FSH Injections Distributors List
Table 118. Recombinant FSH Injections Customers List
Table 119. Recombinant FSH Injections Market Trends
Table 120. Recombinant FSH Injections Market Drivers
Table 121. Recombinant FSH Injections Market Challenges
Table 122. Recombinant FSH Injections Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Recombinant FSH Injections
Figure 2. Global Recombinant FSH Injections Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Recombinant FSH Injections Market Share by Type: 2024 & 2031
Figure 4. Powder Product Picture
Figure 5. Liquid Product Picture
Figure 6. Global Recombinant FSH Injections Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Recombinant FSH Injections Market Share by Application: 2024 & 2031
Figure 8. IVF and Embryo Transfer
Figure 9. Infertility Treatment
Figure 10. Global Recombinant FSH Injections Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Recombinant FSH Injections Market Size (2020-2031) & (US$ Million)
Figure 12. Global Recombinant FSH Injections Sales (2020-2031) & (K Units)
Figure 13. Global Recombinant FSH Injections Average Price (US$/Unit) & (2020-2031)
Figure 14. Recombinant FSH Injections Report Years Considered
Figure 15. Recombinant FSH Injections Sales Share by Manufacturers in 2024
Figure 16. Global Recombinant FSH Injections Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Recombinant FSH Injections Players: Market Share by Revenue in Recombinant FSH Injections in 2024
Figure 18. Recombinant FSH Injections Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Recombinant FSH Injections Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Recombinant FSH Injections Sales Market Share by Country (2020-2031)
Figure 21. North America Recombinant FSH Injections Revenue Market Share by Country (2020-2031)
Figure 22. United States Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Recombinant FSH Injections Sales Market Share by Country (2020-2031)
Figure 25. Europe Recombinant FSH Injections Revenue Market Share by Country (2020-2031)
Figure 26. Germany Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. U.K. Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Recombinant FSH Injections Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Recombinant FSH Injections Revenue Market Share by Region (2020-2031)
Figure 33. China Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. China Taiwan Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Latin America Recombinant FSH Injections Sales Market Share by Country (2020-2031)
Figure 41. Latin America Recombinant FSH Injections Revenue Market Share by Country (2020-2031)
Figure 42. Mexico Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Brazil Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Argentina Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Middle East and Africa Recombinant FSH Injections Sales Market Share by Country (2020-2031)
Figure 46. Middle East and Africa Recombinant FSH Injections Revenue Market Share by Country (2020-2031)
Figure 47. Turkey Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. UAE Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Global Sales Market Share of Recombinant FSH Injections by Type (2020-2031)
Figure 51. Global Revenue Market Share of Recombinant FSH Injections by Type (2020-2031)
Figure 52. Global Recombinant FSH Injections Price (US$/Unit) by Type (2020-2031)
Figure 53. Global Sales Market Share of Recombinant FSH Injections by Application (2020-2031)
Figure 54. Global Revenue Market Share of Recombinant FSH Injections by Application (2020-2031)
Figure 55. Global Recombinant FSH Injections Price (US$/Unit) by Application (2020-2031)
Figure 56. Recombinant FSH Injections Value Chain
Figure 57. Channels of Distribution (Direct Vs Distribution)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Table 1. Global Recombinant FSH Injections Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Recombinant FSH Injections Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Recombinant FSH Injections Market Competitive Situation by Manufacturers in 2024
Table 4. Global Recombinant FSH Injections Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Recombinant FSH Injections Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Recombinant FSH Injections Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Recombinant FSH Injections Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Recombinant FSH Injections Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Recombinant FSH Injections, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Recombinant FSH Injections, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Recombinant FSH Injections, Product Type & Application
Table 12. Global Key Manufacturers of Recombinant FSH Injections, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Recombinant FSH Injections by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant FSH Injections as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Recombinant FSH Injections Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Recombinant FSH Injections Sales by Region (2020-2025) & (K Units)
Table 18. Global Recombinant FSH Injections Sales Market Share by Region (2020-2025)
Table 19. Global Recombinant FSH Injections Sales by Region (2026-2031) & (K Units)
Table 20. Global Recombinant FSH Injections Sales Market Share by Region (2026-2031)
Table 21. Global Recombinant FSH Injections Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Recombinant FSH Injections Revenue Market Share by Region (2020-2025)
Table 23. Global Recombinant FSH Injections Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Recombinant FSH Injections Revenue Market Share by Region (2026-2031)
Table 25. North America Recombinant FSH Injections Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Recombinant FSH Injections Sales by Country (2020-2025) & (K Units)
Table 27. North America Recombinant FSH Injections Sales by Country (2026-2031) & (K Units)
Table 28. North America Recombinant FSH Injections Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Recombinant FSH Injections Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Recombinant FSH Injections Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Recombinant FSH Injections Sales by Country (2020-2025) & (K Units)
Table 32. Europe Recombinant FSH Injections Sales by Country (2026-2031) & (K Units)
Table 33. Europe Recombinant FSH Injections Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Recombinant FSH Injections Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Recombinant FSH Injections Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Recombinant FSH Injections Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Recombinant FSH Injections Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Recombinant FSH Injections Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Recombinant FSH Injections Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Recombinant FSH Injections Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Recombinant FSH Injections Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Recombinant FSH Injections Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Recombinant FSH Injections Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Recombinant FSH Injections Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Recombinant FSH Injections Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Recombinant FSH Injections Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Recombinant FSH Injections Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Recombinant FSH Injections Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Recombinant FSH Injections Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Recombinant FSH Injections Sales (K Units) by Type (2020-2025)
Table 51. Global Recombinant FSH Injections Sales (K Units) by Type (2026-2031)
Table 52. Global Recombinant FSH Injections Sales Market Share by Type (2020-2025)
Table 53. Global Recombinant FSH Injections Sales Market Share by Type (2026-2031)
Table 54. Global Recombinant FSH Injections Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Recombinant FSH Injections Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Recombinant FSH Injections Revenue Market Share by Type (2020-2025)
Table 57. Global Recombinant FSH Injections Revenue Market Share by Type (2026-2031)
Table 58. Global Recombinant FSH Injections Price (US$/Unit) by Type (2020-2025)
Table 59. Global Recombinant FSH Injections Price (US$/Unit) by Type (2026-2031)
Table 60. Global Recombinant FSH Injections Sales (K Units) by Application (2020-2025)
Table 61. Global Recombinant FSH Injections Sales (K Units) by Application (2026-2031)
Table 62. Global Recombinant FSH Injections Sales Market Share by Application (2020-2025)
Table 63. Global Recombinant FSH Injections Sales Market Share by Application (2026-2031)
Table 64. Global Recombinant FSH Injections Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Recombinant FSH Injections Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Recombinant FSH Injections Revenue Market Share by Application (2020-2025)
Table 67. Global Recombinant FSH Injections Revenue Market Share by Application (2026-2031)
Table 68. Global Recombinant FSH Injections Price (US$/Unit) by Application (2020-2025)
Table 69. Global Recombinant FSH Injections Price (US$/Unit) by Application (2026-2031)
Table 70. Gonal-F (Merck) Company Information
Table 71. Gonal-F (Merck) Description and Business Overview
Table 72. Gonal-F (Merck) Recombinant FSH Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Gonal-F (Merck) Recombinant FSH Injections Product
Table 74. Gonal-F (Merck) Recent Developments/Updates
Table 75. Follistim (Organon) Company Information
Table 76. Follistim (Organon) Description and Business Overview
Table 77. Follistim (Organon) Recombinant FSH Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Follistim (Organon) Recombinant FSH Injections Product
Table 79. Follistim (Organon) Recent Developments/Updates
Table 80. Bravelle (Ferring) Company Information
Table 81. Bravelle (Ferring) Description and Business Overview
Table 82. Bravelle (Ferring) Recombinant FSH Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Bravelle (Ferring) Recombinant FSH Injections Product
Table 84. Bravelle (Ferring) Recent Developments/Updates
Table 85. Menopur (Ferring) Company Information
Table 86. Menopur (Ferring) Description and Business Overview
Table 87. Menopur (Ferring) Recombinant FSH Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Menopur (Ferring) Recombinant FSH Injections Product
Table 89. Menopur (Ferring) Recent Developments/Updates
Table 90. Fostimon (IBSA) Company Information
Table 91. Fostimon (IBSA) Description and Business Overview
Table 92. Fostimon (IBSA) Recombinant FSH Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Fostimon (IBSA) Recombinant FSH Injections Product
Table 94. Fostimon (IBSA) Recent Developments/Updates
Table 95. Puregon (Organon) Company Information
Table 96. Puregon (Organon) Description and Business Overview
Table 97. Puregon (Organon) Recombinant FSH Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Puregon (Organon) Recombinant FSH Injections Product
Table 99. Puregon (Organon) Recent Developments/Updates
Table 100. BEMFOLA (Gedeon Richter) Company Information
Table 101. BEMFOLA (Gedeon Richter) Description and Business Overview
Table 102. BEMFOLA (Gedeon Richter) Recombinant FSH Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. BEMFOLA (Gedeon Richter) Recombinant FSH Injections Product
Table 104. BEMFOLA (Gedeon Richter) Recent Developments/Updates
Table 105. Follitrope (LG Chem) Company Information
Table 106. Follitrope (LG Chem) Description and Business Overview
Table 107. Follitrope (LG Chem) Recombinant FSH Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Follitrope (LG Chem) Recombinant FSH Injections Product
Table 109. Follitrope (LG Chem) Recent Developments/Updates
Table 110. GenSci Company Information
Table 111. GenSci Description and Business Overview
Table 112. GenSci Recombinant FSH Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. GenSci Recombinant FSH Injections Product
Table 114. GenSci Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Recombinant FSH Injections Distributors List
Table 118. Recombinant FSH Injections Customers List
Table 119. Recombinant FSH Injections Market Trends
Table 120. Recombinant FSH Injections Market Drivers
Table 121. Recombinant FSH Injections Market Challenges
Table 122. Recombinant FSH Injections Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Recombinant FSH Injections
Figure 2. Global Recombinant FSH Injections Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Recombinant FSH Injections Market Share by Type: 2024 & 2031
Figure 4. Powder Product Picture
Figure 5. Liquid Product Picture
Figure 6. Global Recombinant FSH Injections Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Recombinant FSH Injections Market Share by Application: 2024 & 2031
Figure 8. IVF and Embryo Transfer
Figure 9. Infertility Treatment
Figure 10. Global Recombinant FSH Injections Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Recombinant FSH Injections Market Size (2020-2031) & (US$ Million)
Figure 12. Global Recombinant FSH Injections Sales (2020-2031) & (K Units)
Figure 13. Global Recombinant FSH Injections Average Price (US$/Unit) & (2020-2031)
Figure 14. Recombinant FSH Injections Report Years Considered
Figure 15. Recombinant FSH Injections Sales Share by Manufacturers in 2024
Figure 16. Global Recombinant FSH Injections Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Recombinant FSH Injections Players: Market Share by Revenue in Recombinant FSH Injections in 2024
Figure 18. Recombinant FSH Injections Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Recombinant FSH Injections Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Recombinant FSH Injections Sales Market Share by Country (2020-2031)
Figure 21. North America Recombinant FSH Injections Revenue Market Share by Country (2020-2031)
Figure 22. United States Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Recombinant FSH Injections Sales Market Share by Country (2020-2031)
Figure 25. Europe Recombinant FSH Injections Revenue Market Share by Country (2020-2031)
Figure 26. Germany Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. U.K. Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Recombinant FSH Injections Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Recombinant FSH Injections Revenue Market Share by Region (2020-2031)
Figure 33. China Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. China Taiwan Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Latin America Recombinant FSH Injections Sales Market Share by Country (2020-2031)
Figure 41. Latin America Recombinant FSH Injections Revenue Market Share by Country (2020-2031)
Figure 42. Mexico Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Brazil Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Argentina Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Middle East and Africa Recombinant FSH Injections Sales Market Share by Country (2020-2031)
Figure 46. Middle East and Africa Recombinant FSH Injections Revenue Market Share by Country (2020-2031)
Figure 47. Turkey Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. UAE Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Global Sales Market Share of Recombinant FSH Injections by Type (2020-2031)
Figure 51. Global Revenue Market Share of Recombinant FSH Injections by Type (2020-2031)
Figure 52. Global Recombinant FSH Injections Price (US$/Unit) by Type (2020-2031)
Figure 53. Global Sales Market Share of Recombinant FSH Injections by Application (2020-2031)
Figure 54. Global Revenue Market Share of Recombinant FSH Injections by Application (2020-2031)
Figure 55. Global Recombinant FSH Injections Price (US$/Unit) by Application (2020-2031)
Figure 56. Recombinant FSH Injections Value Chain
Figure 57. Channels of Distribution (Direct Vs Distribution)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global LED Light Housing Market Research Report 2025
Sep 24, 25
Global Side Emitting LED Strip Light Market Research Report 2025
Sep 24, 25
Global Medium and Low Voltage Unshielded Cable Market Research Report 2025
Sep 24, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232